CICLOPIROX OLAMINE
- Product NDC
- 69315-309
- 11-digit product format
- 693150309
- Labeler code
- 69315
- Product ID
- 69315-309_232bf664-5638-47a3-a464-440467039140
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CICLOPIROX OLAMINE
- Dosage form
- SUSPENSION
- Route
- TOPICAL
- Labeler
- Leading Pharma, LLC
- Application
- NDA019824
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2016-12-01
- Marketing end
- 0000-00-00
- Substance
- CICLOPIROX OLAMINE
- Active strength
- 8 mg/mL
- Pharmacologic classes
- Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69315-309-30 | CICLOPIROX OLAMINE | 30 mL in 1 BOTTLE | SUSPENSION | 30 | | 2 |
| 69315-309-60 | CICLOPIROX OLAMINE | 60 mL in 1 BOTTLE | SUSPENSION | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69315-309 | CICLOPIROX OLAMINE SUSPENSION [LEADING PHARMA, LLC] | 2 | Legacy NDC, 2 package rows | 20201218_370ab878-2753-435f-ae06-67ec9f9502e1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69315-309-30 | 69315030930 | 30 mL in 1 BOTTLE (69315-309-30) | 30 ml | 2019-02-25 | 0000-00-00 | No | No | Current |
| 69315-309-60 | 69315030960 | 60 mL in 1 BOTTLE (69315-309-60) | 60 ml | 2019-02-25 | 0000-00-00 | No | No | Current |